Genocea Biosciences News
Most Popular Genocea Biosciences Story
Genocea names CEO, pockets $23M in series A
Genocea Biosciences' work in vaccine discovery has won over a lineup of venture capital groups which are investing $23 million in the developer. The money is earmarked for five development programs,... Read more...
Latest Headlines
- February 19, 2009
- July 10, 2008
- April 24, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
